Clinical Trial Update: A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study of TNB-383B for relapsed or refractory multiple myeloma, sponsored by AbbVie, with status currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TNB-383B

Snippet

Sponsor: AbbVie | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING